A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD
General Information
Age Group
Pediatrics/Children
Status
Active
Protocol Number
AAML1031
Offered At
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
